Wolfe Research initiated coverage of Vera Therapeutics (VERA) with an Outperform rating and $49 price target The firm is bullish on the stock ...
Wolfe Research analyst Andy Chen initiated coverage of Oruka Therapeutics (ORKA) with an Outperform rating and $20 price target. Investors are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback